Total planned funding: $166,121,943
Allocations
Countries/Regions
India | $166,121,943 |
Organizational Types
Unknown | $79,863,673 |
NGO | $40,193,141 |
Own Agency | $23,679,926 |
University | $10,791,895 |
Multi-lateral Agency | $3,116,808 |
Implementing Agency | $3,100,000 |
Private Contractor | $2,409,000 |
FBO | $1,400,000 |
Host Country Government Agency | $940,200 |
Other USG Agency | $627,300 |
Program Areas
Governance and Systems | $72,737,568 |
Prevention | $38,800,134 |
Management and Operations | $17,817,828 |
Care | $17,581,610 |
Treatment | $7,449,438 |
Testing | $7,307,573 |
Budget Codes
OHSS: Health Systems Strengthening | $41,740,027 |
HVSI: Strategic Information | $25,062,005 |
HVOP: Sexual Prevention: Other Sexual Prevention | $19,739,689 |
HVMS: Management and Operations | $17,817,828 |
HBHC: Care: Adult Care and Support | $10,278,130 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $7,309,611 |
HVCT: Testing: HIV Testing and Counseling | $7,307,573 |
HTXS: Treatment: Adult Treatment | $6,954,803 |
HLAB: Laboratory Infrastructure | $5,935,536 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $5,721,759 |
HKID: Care: Orphans and Vulnerable Children | $3,521,260 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $3,245,396 |
HVTB: Care: TB/HIV | $3,148,897 |
HMBL: Biomedical Prevention: Blood Safety | $2,773,679 |
PDCS: Care: Pediatric Care and Support | $633,323 |
PDTX: Treatment: Pediatric Treatment | $471,158 |
HTXD: Treatment: ARV Drugs | $23,477 |
HMIN: Biomedical Prevention: Injection Safety | $10,000 |
Top Partner Programs
Not Available:
$79,239,184
Countries/Regions
FHI 360:
$13,509,571
Countries/Regions
USG Aggregated Agencies:
$11,414,306
Countries/Regions
Voluntary Health Services:
$7,450,000
Countries/Regions